Jul 12, 2022 | Articles, News

Drug Safety and Pharmacovigilance Services Solutions (DSS) rebrand as Qinecsa Solutions

Patient safety is at the forefront of pharmacovigilance. In a demanding and constantly evolving field, life science companies need expert partners with the right people, processes, and technologies, to generate vital safety insights, rapidly.
A trusted partner to global life science companies, Qinecsa brings together best-in-class technology and scientific expertise to connect life science companies to the right safety solutions. Through unique insight into the challenges of pharmacovigilance, Qinecsa provide industry-leading, end-to-end solutions for capturing, managing, and evaluating drug safety data, more efficiently and accurately.
“Following our acquisition by private equity firm Stanley Capital, we have developed a new brand identity that will reintroduce us to the market with a dynamic look, feel, and name that reflects our future ambitions for business growth and diversification.” Humaira Qureshi, CEO of Qinecsa Solutions.
Qinecsa is advancing drug safety solutions to the next level, working with life science companies to drive progress and help them to continue protecting lives.

Services

Complete pharmacovigilance and medical information services delivered by a highly experienced scientific and medical team, in line with global regulatory requirements.

Solutions

Unique, end-to-end solutions to capture, manage, and evaluate drug safety data, more efficiently and accurately.

Technology

Industry-leading technologies that integrate with the pharmacovigilance landscape to streamline business processes and deliver more, better, and faster data across all intake routes.

Resources